Financial Statements

AnPac Bio-Medical Science Co., Ltd. (ANPC)

$0.2999

+0.01 (+1.70%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2020 2019 2018 2017
Retained Earnings (Previous Year) -276-174-132-
Net Income -80-101-42-39
Stock Dividends --1--93
Dividend Paid ----
Retained Earnings -357-276-174-132

PPE Schedule

Year 2020 2019 2018 2017
Gross PPE 191819-
Annual Depreciation 34221
Capital Expenditure -2-3-3-3
Net PPE 19191819

Intangible and Goodwill Schedule

Year 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -222
New Purchases -7-14-21-
Intangible and Goodwill 2222

AnPac Bio-Medical Science Co., Ltd. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AnPac Bio-Medical Science Co., Ltd. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.